Keto CTA study was incredible. It will go down in history, thanks to this conclusion.
Mandrola critique: KETO-CTA did not upend the causal evidence for LDL in atherosclerosis
Gokhan shares a Medscape review by John Mandrola of the KETO-CTA study in lean mass hyper-responders on keto. The review says the data are nowhere near supporting the authors' outsized claims that high LDL-C does not relate to atherosclerosis.



